Product image of Moloxin (Moxifloxacin) supplied by GNH India

Moloxin

Active Ingredient:
Moxifloxacin
Origin:
EU

Moloxin (Moxifloxacin)

Moxifloxacin, the active ingredient in Moloxin, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It is indicated for the treatment of bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, exacerbations of chronic bronchitis, and skin and soft‑tissue infections in adults. The drug is prescribed by qualified healthcare professionals based on clinical assessment.

GNH India supplies Moloxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide and adheres to EU quality standards.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moloxin (moxifloxacin) is used to treat bacterial infections affecting the respiratory tract and skin.

  • Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves clinical outcomes.
  • Acute bacterial sinusitis: reduces sinus inflammation and clears the infection.
  • Acute bacterial exacerbation of chronic bronchitis: controls bacterial load and relieves symptoms.
  • Skin and soft tissue infections: eliminates susceptible organisms and promotes healing.
  • Acute bacterial exacerbation of chronic bronchitis: restores lung function and prevents further deterioration.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these targets, the drug prevents bacterial cell division and leads to bacterial cell death, providing a bactericidal effect against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Side Effects

Moloxin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools that may be watery.
  • Headache: transient cranial discomfort.
  • Dizziness: sensation of light‑headedness.
  • Rash: mild skin erythema or itching.
  • Abdominal pain: cramp‑like discomfort.

Serious or Rare Side Effects

  • Tendon rupture: sudden tendon pain or loss of function.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Severe allergic reactions: anaphylaxis, swelling, or breathing difficulty.
  • Clostridioides difficile infection: severe colitis with watery diarrhea.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.
  • Peripheral neuropathy: numbness or tingling in extremities.

Precautions & Warnings

When prescribing Moloxin, clinicians should consider several precautionary measures to minimize risk.

  • Renal function assessment: adjust use in patients with impaired kidney function.
  • Tendon monitoring: advise patients to report tendon pain or swelling promptly.
  • QT prolongation risk: avoid in patients with known cardiac conduction abnormalities.
  • Elderly caution: increased susceptibility to adverse events; monitor closely.
  • Concomitant QT‑prolonging drugs: evaluate potential additive effects.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Moloxin can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: reduce absorption of moxifloxacin.
  • Warfarin: may increase bleeding risk.
  • Theophylline: elevated plasma levels can cause toxicity.
  • Cyclosporine: increased risk of nephrotoxicity.
  • NSAIDs: heightened seizure risk.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: possible reduction in efficacy.
  • Corticosteroids: increased risk of tendon rupture.
  • Diabetic agents: potential for hypoglycemia.
  • SSRIs: additive effect on QT interval.
  • Rifampicin: may lower moxifloxacin concentrations.

Frequently Asked Questions

Moloxin contains moxifloxacin and is prescribed for adult patients with community‑acquired bacterial pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and skin and soft‑tissue infections caused by susceptible bacteria.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication and transcription. This inhibition stops bacterial cell division, leading to a bactericidal effect against a broad range of Gram‑positive and Gram‑negative organisms.

The dosage of Moloxin is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Patients should follow the exact regimen provided by their healthcare professional.

The pregnancy category for moxifloxacin is not clearly established, and safety data are limited. It should only be used during pregnancy or lactation if the potential benefit outweighs the potential risk, as decided by the treating physician.

To request Moloxin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moloxin (moxifloxacin) offers a broader spectrum against both Gram‑positive and Gram‑negative bacteria compared with some older fluoroquinolones, and it has enhanced activity against respiratory pathogens. However, safety considerations such as tendon risk and QT prolongation remain similar across the class.

Moloxin should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight to maintain stability and potency.

Moloxin is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water and do not crush or chew it unless instructed otherwise.

Serious risks include tendon rupture, especially in the Achilles tendon, QT interval prolongation that can lead to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare cases of hepatic dysfunction or peripheral neuropathy.

Moloxin is contraindicated in patients with a known hypersensitivity to moxifloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and individuals with established QT prolongation or uncontrolled cardiac arrhythmias.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT